semaglutide cardiovascular outcomes news 2025 today Oral Reduces Events in People with Type 2 Diabetes with Atherosclerotic Cardiovascular and/or Chronic Kidney Disease: Primary Results From the SOUL Randomized Trial SELECT Trial – ACC 2025: Oral Semaglutide Reduces

US$ 23.76

★★★★★ 4.0 (10 reviews)

US$ 24.77

★★★★★ 4.3 (14 reviews)

US$ 20.48

★★★★★ 4.6 (12 reviews)

US$ 27.78

★★★★★ 4.9 (24 reviews)

US$ 28.69

★★★★★ 4.2 (8 reviews)

US$ 21.07

★★★★★ 4.8 (11 reviews)

US$ 25.96

★★★★★ 4.2 (12 reviews)

US$ 28.32

★★★★★ 4.2 (9 reviews)

US$ 23.12

★★★★★ 4.9 (10 reviews)

US$ 22.39

★★★★★ 4.7 (22 reviews)

US$ 25.79

★★★★★ 4.3 (10 reviews)

US$ 24.43

★★★★★ 4.4 (22 reviews)

US$ 28.21

★★★★★ 4.5 (8 reviews)

US$ 28.89

★★★★★ 5.0 (11 reviews)

US$ 22.31

★★★★★ 4.6 (18 reviews)

US$ 23.22

★★★★★ 4.0 (26 reviews)

US$ 25.76

★★★★★ 5.0 (12 reviews)

US$ 20.46

★★★★★ 4.5 (11 reviews)

US$ 29.90

★★★★★ 4.0 (12 reviews)

US$ 22.06

★★★★★ 4.2 (10 reviews)